Literature DB >> 10886486

The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.

E Ehrenborg1, J Skogsberg, G Ruotolo, V Large, P Eriksson, P Arner, A Hamsten.   

Abstract

OBJECTIVES: To investigate whether a substitution of glutamine by glutamic acid at amino acid position 27 (Q/E27) and an arginine to glycine transition at amino acid 16 (R/G16) in the beta2-adrenoceptor gene are associated with lipid and lipoprotein disturbances and/or increased body weight in men.
DESIGN: Population-based study.
SETTING: Department of medicine at a university hospital.
SUBJECTS: A total of 180 healthy men, aged 30-45 years, were recruited at random from a register containing all permanent residents in Stockholm County (response rate of 70%). MAIN OUTCOME MEASURES: Frequency of beta2-adrenoceptor genotypes and alleles in relation to plasma lipid and lipoprotein levels and body mass index.
RESULTS: Individuals carrying the E27 allele and/or the G16 allele had significantly higher body mass index (BMI). Furthermore, carriers of the E27 allele had significantly higher plasma concentrations of cholesterol, triglycerides, VLDL cholesterol and VLDL triglycerides than did subjects homozygous for the Q allele.
CONCLUSION: The E27 allele of the beta2-adrenoceptor gene is associated with slightly to moderately elevated BMI and dyslipoproteinaemia involving triglyceride-rich lipoproteins in healthy younger and middle-aged men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886486     DOI: 10.1046/j.1365-2796.2000.00669.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.

Authors:  Orly Vardeny; Gabriel Nicholas; Alina Andrei; Kevin A Buhr; Matt P Hermanson; John J Moran; Michelle A Detry; James H Stein
Journal:  Am J Hypertens       Date:  2012-05-31       Impact factor: 2.689

2.  Frequencies of the Arg16Gly, Gln27Glu and Thr164Ile Adrenoceptor β2 Polymorphisms among Omanis.

Authors:  Khalid Al-Balushi; Fahad Zadjali; Sawsan Al-Sinani; Al-Muatasim Al-Zadjali; Riad Bayoumi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

Review 3.  Very important pharmacogene summary ADRB2.

Authors:  Augusto A Litonjua; Li Gong; Qing Ling Duan; Jaekyu Shin; Mariellen J Moore; Scott T Weiss; Julie A Johnson; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

4.  Association of Gln27Glu and Arg16Gly polymorphisms in Beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis.

Authors:  Hongxiu Zhang; Jie Wu; Lipeng Yu
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

5.  Association of ADRB2 polymorphism with triglyceride levels in Tongans.

Authors:  Izumi Naka; Jun Ohashi; Ryosuke Kimura; Tsukasa Inaoka; Yasuhiro Matsumura
Journal:  Lipids Health Dis       Date:  2013-07-23       Impact factor: 3.876

6.  Relationship between polymorphisms in beta -2 adrenergic receptor gene and ischemic stroke in North Indian Population: a hospital based case control study.

Authors:  Amit Kumar; Manjari Tripathi; Madakasira Vasantha Padma Srivastava; Subbiah Vivekanandhan; Kameshwar Prasad
Journal:  BMC Res Notes       Date:  2014-06-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.